Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal Adenocarcinoma

GEAC carcinogenesis appears to be partially driven via loss or inhibition of FXR on progenitor cells at the gastroesophageal junction. Considering that the resulting aggravation in the phenotype could be reversed with OCA treatment, we suggest that FXR agonists have great potential as a preventive strategy against GEAC progression.

Authors

Institutions

Publication Details

Journal
Cellular and Molecular Gastroenterology and Hepatology
Published
2025-01-01
DOI
https://doi.org/10.1016/j.jcmgh.2025.101505
Citations
7
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
10.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal Adenocarcinoma

Veronika Somoza, Akanksha Anand, Martin Borgmann, Yiwei Sun et al.
7 citations
Cellular and Molecular Gastroenterology and Hepatology
Gastric Cancer Management and Outcomes
10.63
article

Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal Adenocarcinoma

Veronika Somoza, Akanksha Anand, Martin Borgmann, Yiwei Sun, Mohammed Khiat, Chen Meng, Katrin Böttcher, Harris H. Wang, Dirk Haller, Michael Quante, Linus Schömig, Andreas Dunkel, Robert Thimme, Deepa T. Patil, Elke Burgermeister, Andrea Proaño-Vasco, Sinah Reiter, Theresa Baumeister, Julian A. Abrams, Julia Strangmann, Amira Metwaly, Karin Kleigrewe, Timothy C. Wang, Yiming Huang, Alexander Kuznetsov, Roland M. Schmid
article en
7 citations

Abstract

GEAC carcinogenesis appears to be partially driven via loss or inhibition of FXR on progenitor cells at the gastroesophageal junction. Considering that the resulting aggravation in the phenotype could be reversed with OCA treatment, we suggest that FXR agonists have great potential as a preventive strategy against GEAC progression.

Cellular and Molecular Gastroenterology and HepatologyVol. 19(8)
University of Freiburg (DE), Heidelberg University (DE), Columbia University Irving Medical Center (US), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Klinik und Poliklinik für Urologie (DE), Leibniz-Institute for Food Systems Biology at the Technical University of Munich (DE), University Medical Centre Mannheim (DE), Case Western Reserve University (US), Technical University of Munich (DE), Heidelberg University (US)
Wilhelm Sander-Stiftung, Deutsche Forschungsgemeinschaft, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 2%
Gastric Cancer Management and Outcomes
10.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.